Effects of long-term therapy with quetiapine and olanzapine on parameters of immunity and cytokine levels in patients with schizophrenia

Introduction The study of effects of long-term antipsychotic therapy in patients with schizophrenia is relevant. Objectives To study effects of long-term antipsychotic therapy on parameters of immunity and cytokine levels in patients with schizophrenia. Methods We examined 20 schizophrenic pat...

Full description

Bibliographic Details
Published in:	European Psychiatry
Main Authors:	O. Lobacheva, V. Nikitina, E. Kornetova, S. Vladimirova, A. Semke
Format:	Article
Language:	English
Published:	Cambridge University Press 2021-04-01
Subjects:	Psychoneuroimmunology schizophrénia Antipsychotics
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933821020253/type/journal_article

Similar Items

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
by: Adriano Aquino, et al.
Published: (2018-05-01)

Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01)

CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
by: Ye. G. Kornetova, et al.
Published: (2015-02-01)

Influence of clinical and therapeutic indicators on the severity of neurocognitive deficits in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2020-10-01)

Is there constitutional and morphological predisposition to akathisia in schizophrenic patients receiving antipsychotic therapy?
by: A. A. Goncharova, et al.
Published: (2020-01-01)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
by: Anastasiia S. Boiko, et al.
Published: (2021-05-01)

Olanzapine-induced Pancytopenia: Case Report
by: A Prajnashree, et al.
Published: (2024-11-01)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
by: Hong Jihyung, et al.
Published: (2012-12-01)

Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome
by: Elena G. Kornetova, et al.
Published: (2020-09-01)

Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-05-01)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-06-01)

Risk factors for pneumonia in patients with schizophrenia
by: Takahiro Haga, et al.
Published: (2018-12-01)

Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study
by: Matsuzaki H, et al.
Published: (2021-12-01)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
by: Berger Ariel, et al.
Published: (2012-08-01)

Comparison of ziprasidone and olanzapine on cognitive function in patients with schizophrenia at different stages: a prospective study in Huai’an, China
by: Jingjing Yao, et al.
Published: (2025-10-01)

Comparative analysis of EEG in patients with schizophrenia receiving various atypical antipsychotics
by: S. A. Galkin, et al.
Published: (2024-04-01)

Weight Gain, Mental Symptoms and Self-Esteem in Patients with Schizophrenia
by: Sevde Öner, et al.
Published: (2022-12-01)

Olanzapine as a Cause of Urinary Incontinence: A Case Report
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)

Olanzapine as a cause of urinary incontinence: a case report.
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)

Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
by: O. Vasiliu
Published: (2022-06-01)

Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
by: Li Qian, et al.
Published: (2023-08-01)

Olanzapine-induced skin rash: A case report
by: Mansi Shah, et al.
Published: (2019-01-01)

Schizophrenia long-acting antipsychotics initiation index (SLAAII)
by: P. Ifteni, et al.
Published: (2021-04-01)

Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report
by: Xiaobo Xie, et al.
Published: (2025-01-01)

The challenges in schizophrenia treatment in real-life: The uncomfortable truth
by: E. Rancans
Published: (2021-04-01)

A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia
by: Amrita Prakash Singam, et al.
Published: (2011-01-01)

Cytokine Alterations in Schizophrenia: An Updated Review
by: Sara Momtazmanesh, et al.
Published: (2019-12-01)

Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01)

The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
by: Petru Fabian Lungu, et al.
Published: (2024-04-01)

Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
by: Riboldi I, et al.
Published: (2022-12-01)

Chemical and Toxicological Diagnosis of Acute Poisoning with Clozapine, Olanzapine, Quetiapine and Risperidone
by: M. V. Belova, et al.
Published: (2020-10-01)

Differential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents
by: Umme Habiba, et al.
Published: (2023-02-01)

Aripirazole-Long Acting Injectable in Pregnant Women with Schizophrenia: A Case Series
by: B. Fernández-Abascal, et al.
Published: (2022-06-01)

Suicide in Schizophrenia: An Educational Overview
by: Leo Sher, et al.
Published: (2019-07-01)

Medication adherence in schizophrenia: The role of family supervision, dosage frequency and medication knowledge
by: Jombo HE, et al.
Published: (2015-08-01)

Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone
by: Esfandiar Azizi, et al.
Published: (2019-06-01)

Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia
by: Irina A. Mednova, et al.
Published: (2022-11-01)

Adjunctive antidepressive pharmacotherapy in schizophrenia patients
by: M. Zink
Published: (2021-04-01)

Anticholinergic syndrome in a patient with schizophrenia
by: O. Marco Estrada, et al.
Published: (2022-06-01)